These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35667615)

  • 1. Mitochondrial function and Aβ in Alzheimer's disease postmortem brain.
    Troutwine BR; Strope TA; Franczak E; Lysaker CR; Hamid L; Mansel C; Stopperan JA; Gouvion CM; Haeri M; Swerdlow RH; Wilkins HM
    Neurobiol Dis; 2022 Sep; 171():105781. PubMed ID: 35667615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.
    Wilkins HM; Koppel SJ; Bothwell R; Mahnken J; Burns JM; Swerdlow RH
    Redox Biol; 2017 Aug; 12():828-832. PubMed ID: 28448944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
    Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
    Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.
    Soontornniyomkij V; Moore DJ; Gouaux B; Soontornniyomkij B; Tatro ET; Umlauf A; Masliah E; Levine AJ; Singer EJ; Vinters HV; Gelman BB; Morgello S; Cherner M; Grant I; Achim CL
    AIDS; 2012 Nov; 26(18):2327-35. PubMed ID: 23018443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.
    Devi L; Prabhu BM; Galati DF; Avadhani NG; Anandatheerthavarada HK
    J Neurosci; 2006 Aug; 26(35):9057-68. PubMed ID: 16943564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.
    Valla J; Yaari R; Wolf AB; Kusne Y; Beach TG; Roher AE; Corneveaux JJ; Huentelman MJ; Caselli RJ; Reiman EM
    J Alzheimers Dis; 2010; 22(1):307-13. PubMed ID: 20847408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer's disease.
    Mouchard A; Boutonnet MC; Mazzocco C; Biendon N; Macrez N;
    Sci Rep; 2019 Mar; 9(1):3989. PubMed ID: 30850702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan.
    Wang Y; Grydeland H; Roe JM; Pan M; Magnussen F; Amlien IK; Watne LO; Idland AV; Bertram L; Gundersen TE; Pascual-Leone A; Cabello-Toscano M; Tormos JM; Bartres-Faz D; Drevon CA; Fjell AM; Walhovd KW
    Brain Behav Immun; 2022 Feb; 100():243-253. PubMed ID: 34920091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.
    Alikhani N; Guo L; Yan S; Du H; Pinho CM; Chen JX; Glaser E; Yan SS
    J Alzheimers Dis; 2011; 27(1):75-87. PubMed ID: 21750375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4-carriers.
    Wilkins HM; Wang X; Menta BW; Koppel SJ; Bothwell R; Becker AM; Anderson H; Schwartz E; Pei D; Yellapu NK; Chalise P; Gouvion CM; Haeri M; Burns JM; Swerdlow RH
    Aging Cell; 2021 May; 20(5):e13356. PubMed ID: 33939248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.
    Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR;
    Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Aβ
    Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
    Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids variations in amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease.
    Atamna H
    J Bioenerg Biomembr; 2009 Oct; 41(5):457-64. PubMed ID: 19806442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.